Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage - Wikidata - awgldk - TriplyDB

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

http://www.wikidata.org/entity/Q36392740

about

Tirilazad for aneurysmal subarachnoid haemorrhage Transcranial Doppler ultrasonography: From methodology to major clinical applications.Personalized Medicine in Cerebrovascular Neurosurgery: Precision Neurosurgical Management of Cerebral Aneurysms and Subarachnoid Hemorrhage Vascular dysfunction as a target for adjuvant therapy in cerebral malaria Alteration of basilar artery rho-kinase and soluble guanylyl cyclase protein expression in a rat model of cerebral vasospasm following subarachnoid hemorrhage.Correlation of transcranial color Doppler to n20 somatosensory evoked potential detects ischemic penumbra in subarachnoid hemorrhage.Emerging pharmacotherapy of tinnitus.Intra-Arterial Eptifibatide in the Management of Thromboembolism during Endovascular Treatment of Intracranial Aneurysms: Case Series and a Review of the Literature.Management of aneurysmal subarachnoid hemorrhage.Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage Novel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications.Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: A meta-analysis of controlled clinical trials.Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects.Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage.The efficacy and safety of acupuncture for cerebral vasospasm after subarachnoid hemorrhage: study protocol for a randomized controlled trial.EARLYDRAIN- outcome after early lumbar CSF-drainage in aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.Red blood cell transfusion and mortality effect in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis protocol.Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage.Vasospasm Risk in Surgical ICU Patients With Grade I Subarachnoid Hemorrhage Effects of topical administration of nimodipine on cerebral blood flow following subarachnoid hemorrhage in pigs.Year in review 2011: Critical Care--Neurocritical care.Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.Magnesium lithospermate B, an active extract of Salvia miltiorrhiza, mediates sGC/cGMP/PKG translocation in experimental vasospasm.Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage.Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.TRPC Channels and Stroke.Management strategy for treatment of vasospasm following transsphenoidal excision of craniopharyngioma.Subarachnoid hemorrhage admissions retrospectively identified using a prediction model Diagnosis and management of vasospasm.Extradural Hemorrhage: A rare Complication and Manifestation of Stroke in Sickle Cell Disease.Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.A rare case of spontaneous bilateral extradural hematoma in a sickle cell disease child CTP and DCI: We Need Clarification.Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker.Effects of iodinated contrast media in a novel model for cerebral vasospasm.Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.The role of intravenous immunoglobulin in the treatment of cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study.Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.

P2860

Q24240010-238B5E72-C7D1-4AA6-BD5B-02E3CEA6D95D Q26741104-20F873CB-94B2-47DF-BA53-E384A4934E26 Q26742076-5FCDDE38-BD6A-4265-BE1E-C7773EB36528 Q27025436-391E257A-7C6F-47F7-99A8-C38CC72FF434 Q30412258-9F586BF3-81D1-4009-8626-108FD08D45E0 Q30475178-EE269EB0-4549-4AD1-9434-C7E5421895EE Q30478378-A1A1CA43-7525-456D-BA36-1E24C1D8FF04 Q33417495-37E75DF0-3459-4C30-8143-6C6F90BA5F23 Q33645657-C39211B3-39CF-4850-AB90-4AF6A9FFEDEE Q33703727-CD8A6C53-5032-49F3-8C6E-0C26015BC472 Q33913118-27E01C61-B722-48FC-A1D7-8156A9146CC6 Q34043009-3F63535C-5E17-41B7-8534-6CD9C724C5AD Q34068557-14C8B920-9CB6-4117-BE53-47E9B647A6EF Q34583326-A9AA15FB-EEB9-4C50-A4B9-5C8638360C15 Q34652720-5C2CA07B-8C28-40EC-9D7C-F9A53EB4E827 Q35155512-377ED674-097E-412F-AE09-7BC43AC31B4B Q35233096-767459A8-AC4E-4CFC-AFD7-388C2D8E3219 Q35358901-3374ABA1-DB5C-4F83-8FB8-2910EB633BE3 Q35574105-1CF33516-4033-402F-AA54-B0F9996E6FD7 Q36304010-E289E427-8E36-42CC-B12E-E07938667542 Q36376175-80F6BDD0-0262-4B80-9721-B99224FD8677 Q36795883-5D5DCF95-5A8E-42A6-9AA6-1408AD8B8EB0 Q36902672-FD7729A1-D2CC-47EA-BD16-5CCAA96CB88D Q37672948-DEBBF77F-F996-4205-9AB9-8362D30044C1 Q37718838-E68DD074-3592-4211-BDEE-C350B831423C Q38170048-4BA87986-46CB-429F-860C-D9F754C5E9CE Q38287055-B20FA2ED-FD62-4E28-9A81-7A7259405027 Q38683402-71E9ACD2-20F7-4274-A8E0-533364F9CC75 Q38957300-5590B4AF-2832-44E0-8218-ABD96FE5575B Q39389684-1EDDF508-32D6-4D3F-8B77-2D406B262D18 Q40014449-DD5BD16D-BBF4-4CD2-8235-E9882BFF45CC Q41391679-BA2A37A0-D1B7-4DBD-8545-E9FCDDF0CFEB Q41806888-EDFB458C-5E23-4314-851B-2C50CD23A9EC Q41912840-72E20B66-CE48-4FC0-889D-DFD1E927E1A8 Q48104855-2256F6D7-A1FB-4FC8-9250-E02884E64D32 Q48203672-D0E8FAE1-B38F-4F29-9C91-BB70D2EE732D Q48296190-EF191F6F-130F-4D03-B3A9-E51D54DC993A Q48302008-72F9EB1C-2135-461E-B399-5EE902B22617 Q49064990-F59BB349-1CE1-4BFA-9FF0-F196FFEFA7FB Q49687149-E497CB83-6F07-421D-B258-F625D1BB2832

P2860

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

http://www.wikidata.org/entity/Q36392740

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

@ast

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

@en

type

label

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

@ast

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

@en

prefLabel

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

@ast

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

@en

P1433

Q36392740-ED482A3D-16B0-4543-AEC4-4927A92FD6B8

P1476

Q36392740-64A19CA0-81D5-4218-84D4-9C859F7E6158

P2093

Q36392740-2EEF938A-9F53-4607-852E-16666A8254A1

Q36392740-885116B5-1109-459C-9EEB-2A8F63533E3B

P2860

Q36392740-02CACE36-8B82-4E6C-B68F-6DA2CE124BED

Q36392740-037D422B-CB14-4558-B145-F9769F9F3EAB

Q36392740-0714B178-C3B0-4CCD-9BFD-295EC3C3C7B3

Q36392740-07F952A9-C817-441E-A075-265EF3E2506C

Q36392740-081C6EA2-191B-4E57-B50B-85ABFA54520C

Q36392740-0ABF85AD-8707-4919-A1DA-D6DF2EE9AD5F

Q36392740-0F524989-2B40-4843-AA92-55688450F231

Q36392740-0FB750A0-57B8-4855-B2EB-17279A8F94B7

Q36392740-10EB4C41-8161-4B64-9533-B428F1E0B473

Q36392740-13E1247F-691C-4A1C-9EDC-AD46CE30563B

P2888

Q36392740-D88E7291-11FD-4E16-AF60-2B3A5D4AD0B4

P304

Q36392740-4DA9938F-AFF9-41CA-B608-C970A49E9DA7

P31

Q36392740-1595DC84-8E71-4E5C-8588-82A65810EDD7

Q36392740-BB15D77E-33EB-457C-AAC9-2B3597A3855B

P356

Q36392740-658AF72B-F944-44AB-ABE4-AC1CFA446F8E

P433

Q36392740-40D3532C-7977-4EA1-AF02-E029A4E082CC

P478

Q36392740-752217E6-7362-454D-9C2E-861F8454CA53

P577

Q36392740-F16F3928-53E9-41EC-A5A3-BAB3B743A1D6

P5875

Q36392740-5731F488-1F8C-46F7-8E84-DBCB726272AD

P6179

Q36392740-487904B6-6902-4800-8EC0-C8AC5E794F21

P698

Q36392740-5349D5E1-84A1-4759-A08B-04B884AB4A46

P921

Q36392740-9903A59C-61E8-42A8-B6AC-C949CD6223F2

Q36392740-9D278E57-0805-46BA-91E9-33E220338112

P932

Q36392740-30546E03-2522-4C90-A71E-19671BCD640F

P356

P1433

P1476

Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

@en

P2093

Michael N Diringer

http://www.w3.org/2001/XMLSchema#string

Salah G Keyrouz

http://www.w3.org/2001/XMLSchema#string

P2860

Calcium antagonists for aneurysmal subarachnoid haemorrhage

Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

Molecular cloning of a non-isopeptide-selective human endothelin receptor

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

Cloning and expression of human endothelin-1 receptor cDNA

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.

P2888

P304

220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC5958

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6133745

http://www.w3.org/2001/XMLSchema#string

P6179

1005311393

http://www.w3.org/2001/XMLSchema#string

P698

17705883

http://www.w3.org/2001/XMLSchema#string

P921

intracranial vasospasm

subarachnoid hemorrhage

P932

2206512

http://www.w3.org/2001/XMLSchema#string